-Taurus Rogers Researcher Activity Profile

Research Author Detailed Information 

Taurus Rogers Publication Rate By Year

Taurus Rogers has published 1 paper(s) in 1990, 2 paper(s) in 2006, 8 paper(s) in 2007, 2 paper(s) in 2008, for a total of 13 research publications in total.

Taurus T Rogers Author Information

LAST NAME: rogers

FIRST NAME: Taurus

INITIALS: t

AFFILIATION:

Papers

Taurus Rogers's Publication Record

1. Predominance of nocturnal hypertension in pediatric renal allograft recipients. Year Published: 2006
University of Tennessee Health Science Center, Memphis, TN, USA.
2. Nanostructured calcium phosphates (NanoCaPs) for non-viral gene delivery: influence of the synthesis parameters on transfection efficiency. Year Published: 2006
Department of Biomedical Engineering, Carnegie Mellon University, Pittsburgh, PA 15213, USA.
3. Are we failing workers with symptoms suggestive of occupational asthma? Year Published: 2007
Medical Unit, Health and Safety Laboratory, Harpur Hill, Buxton, UK. d.fishwick@sheffield.ac.uk
4. Association between a positive ED FAST examination and therapeutic laparotomy in normotensive blunt trauma patients. Year Published: 2007
Center for Policy and Research in Emergency Medicine, Department of Emergency Medicine, Oregon Health & Science University, Portland, Oregon 97201-3098, USA.
5. COX-2 inhibitor celecoxib prevents chronic morphine-induced promotion of angiogenesis, tumour growth, metastasis and mortality, without compromising analgesia. Year Published: 2007
1Division of Hematology, Oncology and Transplantation, the Vascular Biology Center, Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA.
6. COX-2 inhibitor celecoxib prevents chronic morphine-induced promotion of angiogenesis, tumour growth, metastasis and mortality, without compromising analgesia. Year Published: 2007
1Division of Hematology, Oncology and Transplantation, the Vascular Biology Center, Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA.
7. COX-2 inhibitor celecoxib prevents chronic morphine-induced promotion of angiogenesis, tumour growth, metastasis and mortality, without compromising analgesia. Year Published: 2007
1Division of Hematology, Oncology and Transplantation, the Vascular Biology Center, Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA.
8. Association between a positive ED FAST examination and therapeutic laparotomy in normotensive blunt trauma patients. Year Published: 2007
Center for Policy and Research in Emergency Medicine, Department of Emergency Medicine, Oregon Health & Science University, Portland, Oregon 97201-3098, USA.
9. COX-2 inhibitor celecoxib prevents chronic morphine-induced promotion of angiogenesis, tumour growth, metastasis and mortality, without compromising analgesia. Year Published: 2007
1Division of Hematology, Oncology and Transplantation, the Vascular Biology Center, Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA.
10. Toward the development of self-help health behaviour change programs: weight loss by correspondence. Year Published: 1990
Department of Health Studies, University of Waterloo, Ontario.
11. Are we failing workers with symptoms suggestive of occupational asthma? Year Published: 2007
Medical Unit, Health and Safety Laboratory, Harpur Hill, Buxton, UK. d.fishwick@sheffield.ac.uk
12. Crystallization and preliminary x-ray analysis of anti-obesity Peptide hormone oxyntomodulin. Year Published: 2008
Department of Chemistry and Biochemistry Program, Indiana University, Bloomington, Indiana 47405, USA. fzhang@indiana.edu.
13. Coronary artery disease in young women and men with long-standing insulin-dependent diabetes. Year Published: 2008
University of Minnesota, Minneapolis, Minnesota, USA.